 |
|
1 sleepless night increases dopamine in the human brain
August 20, 2008Findings may help explain how sleep-deprived people stay alert
Washington, DC - Just one night without sleep can increase the amount of the chemical dopamine in the human brain, according to new imaging research in the August 20 issue of The Journal of Neuroscience. Because drugs that increase dopamine, like amphetamines, promote wakefulness, the findings offer a potential mechanism explaining how the brain helps people stay awake despite the urge to sleep. However, the study also shows that the increase in dopamine cannot compensate for the cognitive deficits caused by sleep deprivation.
"This is the first time that a study provides evidence that in the human brain, dopamine is involved in the adaptations that result from sleep deprivation," said Nora Volkow, MD, director of the National Institute on Drug Abuse, who led the study.
Volkow and colleagues found that in healthy participants, sleep deprivation increased dopamine in two brain structures: the striatum, which is involved in motivation and reward, and the thalamus, which is involved in alertness. The researchers also found that the amount of dopamine in the brain correlated with feelings of fatigue and impaired performance on cognitive tasks.
"These findings suggest dopamine may increase after sleep deprivation as a compensatory response to the effects of increased sleep drive in the brain," said David Dinges, PhD, at the University of Pennsylvania School of Medicine, an expert unaffiliated with the study. "The extent to which this occurs may differentiate how vulnerable people are to the neurobehavioral effects of sleep loss," Dinges said.
The researchers studied 15 healthy participants who were either kept awake all night or allowed a good night's sleep. Researchers tested the same participants in both conditions. On the morning of the study, participants rated how tired they were and did cognitive tasks testing visual attention and working memory.
The researchers used the imaging technique positron emission tomography to study the changes in the dopamine system that occur with sleep deprivation. Compared to well-rested participants, sleep-deprived participants showed reduced binding of a radiolabeled compound ([11C]raclopride) that binds to dopamine receptors in the striatum and thalamus. Because raclopride competes with dopamine for the same receptors, decreased raclopride binding indicates increased levels of dopamine, according to the study authors.
Although decreases in raclopride binding could also indicate a reduction in the number of dopamine receptors, these findings are consistent with prior research implicating increased dopamine levels in wakefulness. For example, some stimulants that prevent sleep, like amphetamines, increase dopamine in the brain, and sleepiness is common in people with Parkinson's disease, which kills dopamine neurons.
The rise in dopamine following sleep deprivation may promote wakefulness to compensate for sleep loss. "However, the concurrent decline in cognitive performance, which is associated with the dopamine increases, suggests that the adaptation is not sufficient to overcome the cognitive deterioration induced by sleep deprivation and may even contribute to it," said study author Volkow.
Future research will examine the long-term effects of chronic sleep disturbances on dopamine brain circuits.
Society for Neuroscience
Volkow and colleagues found that in healthy participants, sleep deprivation increased dopamine in two brain structures: the striatum, which is involved in motivation and reward, and the thalamus, which is involved in alertness. The researchers also found that the amount of dopamine in the brain correlated with feelings of fatigue and impaired performance on cognitive tasks.
"These findings suggest dopamine may increase after sleep deprivation as a compensatory response to the effects of increased sleep drive in the brain," said David Dinges, PhD, at the University of Pennsylvania School of Medicine, an expert unaffiliated with the study. "The extent to which this occurs may differentiate how vulnerable people are to the neurobehavioral effects of sleep loss," Dinges said.
The researchers studied 15 healthy participants who were either kept awake all night or allowed a good night's sleep. Researchers tested the same participants in both conditions. On the morning of the study, participants rated how tired they were and did cognitive tasks testing visual attention and working memory.
The researchers used the imaging technique positron emission tomography to study the changes in the dopamine system that occur with sleep deprivation. Compared to well-rested participants, sleep-deprived participants showed reduced binding of a radiolabeled compound ([11C]raclopride) that binds to dopamine receptors in the striatum and thalamus. Because raclopride competes with dopamine for the same receptors, decreased raclopride binding indicates increased levels of dopamine, according to the study authors.
Although decreases in raclopride binding could also indicate a reduction in the number of dopamine receptors, these findings are consistent with prior research implicating increased dopamine levels in wakefulness. For example, some stimulants that prevent sleep, like amphetamines, increase dopamine in the brain, and sleepiness is common in people with Parkinson's disease, which kills dopamine neurons.
The rise in dopamine following sleep deprivation may promote wakefulness to compensate for sleep loss. "However, the concurrent decline in cognitive performance, which is associated with the dopamine increases, suggests that the adaptation is not sufficient to overcome the cognitive deterioration induced by sleep deprivation and may even contribute to it," said study author Volkow.
Future research will examine the long-term effects of chronic sleep disturbances on dopamine brain circuits.
Society for Neuroscience
Dopamine Current Events and Dopamine News RSSInteraction between gene variants may alter brain function in schizophrenia
A collaborative study led by investigators from Massachusetts General Hospital (MGH) is giving what may be the first look at how interactions between genes underlie a key symptom of schizophrenia, impaired working memory.
Pitt research identifies new target in brain for treating schizophrenia
Research from the University of Pittsburgh could expand the options for controlling schizophrenia by identifying a brain region that responds to more than one type of antipsychotic drug.
New promising obesity drug may have huge potential
According to trials, a new obesity drug, Tesofensine, which may be launched on the world market in a few years, can produce weight loss twice that of currently approved obesity drugs.
ADHD appears to increase level of nicotine dependence in smokers
Young people with ADHD are not only at increased risk of starting to smoke cigarettes, they also tend to become more seriously addicted to tobacco and more vulnerable to environmental factors such as having friends or parents who smoke, according to a study from Massachusetts General Hospital reseachers.
Caltech scientists engineer supersensitive receptor, gain better understanding of dopamine system
Genetically modifying a receptor found on the neurons that produce the neurotransmitter dopamine has given California Institute of Technology (Caltech) researchers a unique glimpse into the workings of the brain's dopamine system--as well as a new target for treating diseases that result from either too much or too little of this critical neurotransmitter.
Lack of vitamin D linked to Parkinson's disease
A majority of Parkinson's disease patients had insufficient levels of vitamin D in a new study from Emory University School of Medicine.
Singing to females makes male birds' brains happy
The melodious singing of birds has been long appreciated by humans, and has often been thought to reflect a particularly positive emotional state of the singer.
Study reveals specific gene in adolescent men with delinquent peers
Birds of a feather flock together, according to the old adage, and adolescent males who possess a certain type of variation in a specific gene are more likely to flock to delinquent peers.
Do 'light' cigarettes deliver less nicotine to the brain than regular cigarettes?
For decades now, cigarette makers have marketed so-called light cigarettes - which contain less nicotine than regular smokes - with the implication that they are less harmful to smokers' health. A new UCLA study shows, however, that they deliver nearly as much nicotine to the brain.
UNC study: Parenting can override effect of genes in how babies respond to stress
Everyone gets stressed, even babies. Now, it appears how infants respond to stress is linked to if they have a particular form of a certain gene, according to a new study from the University of North Carolina at Chapel Hill.
More Dopamine Current Events and Dopamine News Articles
 | Dopamine and Glutamate in Psychiatric Disorders An illuminating summary of our current understanding of the interactive role of dopamine and glutamate in psychiatric diseases and the therapeutic strategies and possibilities for future treatment. Among the new ideas presented are hypotheses on the role of dopamine and glutamate in aggression, the glutamate system in anxiety disorders, glutamate and neurodegeneration, and on the origin and... |
 | Dumb Bells & Dopamine: A Parkinson's Success Story by Arthur, W. Curren This book is about living with Parkinson's, an incurable, debilitating disease caused by the loss of dopamine-producing cells in the brain of the afflicted person. Levodopa is the only drug that replaces some of the dopamine and exercise is the only activity that induces the brain to produce dopamine. The author uses a rigorous exercise program to reduce the dosage of levodopa and extend the... |
 | Dopamine Research Advances Dopamine is a phenethylamine naturally produced by the human body. In the brain, dopamine functions as a neurotransmitter, activating the five types of dopamine receptor - D1, D2, D3, D4 and D5, and their variants. Dopamine is produced in several areas of the brain, including the substantia nigra. Dopamine is also a neurohormone released by the hypothalamus. Its main function as a hormone is to... |
| The Role of Brain Dopamine (Basic and Clinical Aspects of Neuroscience, Vol 3) | |
| The Dopamine Receptors Expert neuroscientists and pharmacologists comprehensively survey the most significant currently active areas of dopamine receptor research. Their authoritative, comprehensive chapters review all the areas of highest current interest, ranging from the molecular structure of dopamine receptors to their functions in the brain and pituitary. Their powerful critical synthesis opens the door to a... | |
| Dopamine Transporters by Mark L./ Izenwasser, Sari/ Wang, Binghe Trudell | |
 | Dopamine, Volume 21 (Handbook of Chemical Neuroanatomy) Dopamine is a major neurotransmitter of the brain involved in the control of movement, emotion, and cognition; disturbance in dopamine function is associated with disorders like Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. This volume of the Handbook of Chemical Neuroanatomy provides a series of in depth critical reviews of our present understanding of the most... |
 | Monkeys in the Middle: How One Drug Company Kept a Parkinsons Disease Breakthrough Out of Reach by Nick Nelson Some said it was a miracle drug; others called it the cure. A drug known simply as "GDNF" seemed to do the impossible by actually reversing the effects of Parkinson's disease. The miracle ended in the fall of 2004 when Amgen Inc. abruptly halted clinical trials of GDNF and denied access to the drug. In "Monkeys in the Middle", investigative reporter Nick Nelson recounts the true story of the... |
| The Mesocorticolimbic Dopamine System (Annals of the New York Academy of Sciences) by Peter W. Kalivas | |
| Distribution of the 3' VNTR Polymorphism in the Human Dopamine Transporter Gene in World Populations.: An article from: Human Biology by R.j. Mitchell, S. Howlett, L. Earl, N.g. White, J. Mccomb, M.s. Schanfield, I. Briceno, S.s. Papiha, L. Osipova, G. Livshits, W.r. Leonard, M.h. Crawford This digital document is an article from Human Biology, published by Wayne State University Press on April 1, 2000. The length of the article is 4403 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... |
| © 2008 BrightSurf.com |